Thomas Gevaert
Brasschaat, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.
Journal: Nature reviews. Urology
Published: March 31, 2026
Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.
Journal: Molecular medicine (Cambridge, Mass.)
Published: February 06, 2026
Multi-omics integration and batch correction using a modality-agnostic deep learning framework.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).
Journal: European urology oncology
Published: September 29, 2025
In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers.
Journal: Nanoscale advances
Published: April 15, 2025
A catheter-associated urinary tract infection mouse model to study bladder dysfunction and pain.
Journal: Pain
Published: February 19, 2025
Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium.
Journal: European urology open science
Published: September 06, 2024
Transforming UTUC diagnostics: the potential of bladder Epicheck® in clinical practice.
Journal: Minerva urology and nephrology
Published: August 02, 2024
Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression.
Journal: European urology open science
Published: June 19, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 23, 2024
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered -omics studies.
Journal: Frontiers in oncology
Published: April 27, 2024
Last Updated: 09/26/2026